Vertex Pharmaceuticals Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 23.2% | 23.2% | 17.4% |
| FY2022 | 23.9% | 23.9% | 18.3% |
| FY2023 | 20.6% | 20.6% | 15.9% |
| FY2024 | -3.3% | -3.3% | -2.4% |
| FY2025 | 21.2% | 21.2% | 15.4% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | 23.2% | 23.2% | 17.4% |
| FY2022 | 23.9% | 23.9% | 18.3% |
| FY2023 | 20.6% | 20.6% | 15.9% |
| FY2024 | -3.3% | -3.3% | -2.4% |
| FY2025 | 21.2% | 21.2% | 15.4% |